From: Hepatic arterial embolization in patients with neuroendocrine tumors
Paper | Number and type of NEN | Number of TAEs | BR | SR (endocrine symptoms) | SR (aspecific symptoms) |
---|---|---|---|---|---|
Loewe et al. 2003[7] | 23 small-bowel NENs | 75 | 13 pts evaluable: 8 (61%) PR, 5 (39%) MR | 9 pts evaluable: | - - - |
 | Abdominal pain 5 (56%) PR |  | |||
 | Diarrhea 2 (22%) CR |  | |||
 | Flushing 2 (22%) CR |  | |||
Gupta et al. 2003[18] | 69 carcinoids | Carcinoids: | - - - | - - - | - - - |
 | 42 TAE/27 TACE |  | |||
 | 54 PNENs | PNENs: |  | ||
 | 32 TAE/22 TACE |  | |||
Carrasco et al. 1986[32] | 25 carcinoids | 25 | 18 (72%) CR | - - - | 20 (87%) CR |
Strosberg et al. 2006[36] | 59 carcinoids | 161 | 35 pts evaluable: | Flushing and/or diarrhea 21 (48%) CR | 9 (20%) CR |
 | 20 PNENs |  | 28 (80%) CR | Abdominal pain 11 (25%) CR | (44 pts evaluable) |
 | 5 unspecified NENs |  | 4 (11%) MR | Hypoglicemia 3 (7%) CR |  |
 | 3 (9%) no response | (44 pts evaluable) |  | ||
Hanssen et al. 1989[39] | 19 carcinoids (7 pts evaluable) | 7 | 7 (100%) PR | Diarrhea and/or flushing: 7 (100%) CR | - - - |
Wangberg et al. 1996[40] | 64 carcinoids | 40 | 40 (100%) PR | - - - | 40 (100%) PR |
 | (40 pts evaluable) |  | |||
Eriksson et al. 1998[41] | 29 carcinoids | 55 | Carcinoids: 12 (41%) PR, 8 (28%) MR, 9 (31%) no response | - - - | 11 carcinoid (38%) CR |
 | 12 PNENs |  | PNEN: 6 (50%) PR, 2 (16%) MR, 4 (34%) no response |  | 6 PNEN (50%) CR |
Brown et al. 1999[42] | 21 carcinoids | 63 | - - - | - - - | 46 (96%) PR |
 | 14 PNENs | (48 evaluable) |  | (48 TAE evaluable) | |
Chamberlain et al. 2000[43] | 41 carcinoids | 59 | - - - | 33 pts evaluable | 31 (94%) PR |
 | 26 non functional PNENs |  | Hormonal and/or pain symptoms |  | |
 | 18 functional PNENs |  | 31 (94%) PR |  | |
Ruutiainen et al. 2007[44] | 67 unspecified NENs | 23 TAE/44 TACE (219 procedures) | - - - | - - - | - - - |
Ho et al. 2007[45] | 46 NENs | 7TAE/86 TACE | - - - | - - - | 27 pts evaluable |
 | (31 carcinoids; 15 PNEN) |  | 21 (78%) PR | ||
Kamat et al. 2008[46] | 60 unspecified NENs | 33 TAE/27 TACE | - - - | - - - | 20 pts evaluable |
 | (123 procedures) |  | 13 (65%) PR | ||
Pitt et al. 2008[47] | 100 unspecified NENs | 106TAE/123TACE | - - - | - - - | 35 pts evaluable: 29 TAE (83%) PR |
 | 35 pts evaluable: 32 TACE (86%) PR | ||||
Sward et al. 2009[48] | 107 carcinoids | 213 | 37 pts evaluable: | Diarrhea and/or flushing 76 (71%) CR | 76 (71%) |
 | CgA: 19 (51%) CR |  | |||
 | 54 pts evaluable: |  | |||
 | 5HIAA: 26 (48%) CR |  | |||
Fiore et al. 22014[50] | 12 PNENs | 38 TAE/37 TACE | - - - | - - - | 19 pts evaluable |
 | 16 NENs ileum |  | (64%) PR* | ||
 | 2 NENs colon |  |